The FDA has approved a supplemental application for Gardasil 9, Merck’s HPV vaccine for men and women ages 27-45. “Today’s approval represents an important opportunity to help prevent HPV-related diseases and cancers in a broader age range,” Peter Marks, MD, PhD, director of …
Read more via...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.